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Digital versatile discs as platforms for multiplexed genotyping 
based on selective ligation and universal microarray detection 
Luis A. Tortajada-Genaro*, a,b,c, Regina Niñolesb,d, Salvador Menab, Ángel Maquieiraa,b,c 
Developing high-performance assays readout by integrated detectors is a current challenge to implement DNA tests into 
diagnostic laboratories, particularly for supporting pharmacogenetic tests. A method for allelic discrimination, associated 
with single nucleotide polymorphisms (SNPs), is presented. Genomic DNA is extracted from blood and buccal swab samples. 
The procedure comprises fast multiplex ligation-dependent probe amplification, PCR amplification using universal primers 
and subsequent barcode hybridization. In this last step, each product is recognized by the specific probes immobilized on 
the surface of an optical disc. Assay results can be collected with a disc reader. The optical sensing method in a DNA 
microarray format was optimized and evaluated for the simultaneous identification of 28 polymorphisms associated with 
psychiatry pharmacogenomics. The target biomarkers were located in the genes related to drug-metabolizing enzymes and 
drug transporters. The multiplexing capability and assay selectivity strongly depended on correct design (ligation probes, 
tails and barcodes). The discriminant analysis of reader outputs (spot intensities) led to patients being classified into different 
allelic populations. The obtained assignations correlated properly with the results provided by the reference technique (bead 
arrays), and the assay ended in an 8-fold shorter time using affordable equipment. The combination of high selective 
genotyping reaction as array-MLPA and the compact disc technology provide a reliable point-of-care approach. This 
genotyping tool is useful for selecting personalized drug therapies in decentralized clinical laboratories.
Introduction 
Individuals often show different clinical evolutions for the same 
disease or treatment. In recent years, molecular technologies 
have identified genetic biomarkers associated with drug 
metabolism and transportation, where single-nucleotide 
polymorphisms (SNPs) are the most abundant and relevant. 1,2 
These relationships between genetic populations and drug 
response have been successfully applied to decision making.3 In 
fact pharmacogenomics is currently considered one of the most 
actionable areas of the personalized medicine paradigm.4 As a 
result, clinical practice guidelines based on genetic variants of 
specific SNPs have been defined to increase treatment 
efficiency and to minimize adverse reactions.5  
Genetic assays have been simultaneously developed for the 
accurate genotyping of SNPs in a given DNA sample.6-8 However, 
the availability of high-throughput techniques (e.g. bead arrays, 
sequencers) in healthcare systems is poor given their costs for 
instrumental and personal resources.9 Authors claim that the 
personalized medicine paradigm will be achieved when 
alternative approaches with a reasonable impact on current 
clinical activities can be applied.10 Therefore, the research 
challenge involves developing technologies that integrate 
essential properties with functional properties such as low cost, 
flexibility, portability or simplicity. In particular, instruments 
designed for point-of-care (POC) applications offer rapid 
sample-to-result assays to be performed at or near the site of 
clinical care.11,12 The goal involves integrating an allele-selective 
assay and a method to report the presence of the targeted 
variant or variants. 
Multiplex ligation-dependent probe amplification (MLPA) is the 
most relevant technique, which was originally designed to 
detect copy number variations.13 Further modifications have 
provided new applications, including methylation status 
determination, the relative quantification of mRNAs and SNP 
genotyping.14-17 Typically, benchtop capillary electrophoresis 
equipment detects the fluorescent-labeled products of the 
allele-specific ligation, while the peak pattern determines 
sample genotyping. However, conventional MLPA introduces 
several constraints to generate specific products for SNP 
genotyping. For instance, the analysis of up to 50 target 
sequences simultaneously involves each ligated probe and gives 
rise to a PCR product of a specific length ranging from 90 to 500 
bp. The consequences are complex probe design, restrictive 
ligation conditions and differences in amplification yield. There 
is an interesting approach, called array-MLPA, which focuses on 
detecting deletions and duplications,18 pathogens,19 and cancer 
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biomarkers.20 In this method, the enzymatic reaction is 
combined with a universal microarray by including barcode 
sequences in ligation probes. Then each targeted region is 
identified according to the location on the chip where the 
unique barcode sequence is immobilized. Two detection 
principles have been proposed for array-MLPA: conventional 
fluorescent scanning of glass slides and pulse amperometric 
readout of gold electrode array.18-20 These approaches imply 
major barriers for real integration into clinical practice. 
Several research groups have demonstrated that consumer 
electronic devices, such as compact disc, smartphone and 
flatbed scanner, can be used as DNA diagnostic tools.21-23 Their 
application to genotype genetic variants, based on allele-
specific amplification or hybridization, suffer limited 
multiplexing capability (less than 5 SNPs simultaneously) due to 
restrictive assay conditions. The objective of the present study 
was to develop a modified array-MLPA methodology, combined 
with compact disc technology, for a fast, sensitive SNP 
genotyping analysis to fulfil POC test requirements. Since the 
analytical platform is a digital versatile disc (DVD), the method 
is called DVD-array-MLPA (Fig.1). We exploit the advantages of 
an easy, cheap, robust, user-friendly, portable, mass-produced 
technology that is compatible with biosensing.24 Our research 
focused on modifying the ligation reaction by implementing a 
barcode microarray on the disc surface and colorimetrically 
reading the results using a disc drive as a multiplex genotyping 
tool. 
Results and discussion 
1. Improving the ligation process 
The first step of the proposed approach (DVD-array-MLPA) 
relies on the hybridization and ligation of two adjacently 
situated oligonucleotides to a specific genomic DNA sequence 
(discrimination ligation probe and common ligation probe). 
Depending on the allele to be detected, the probe was designed 
to contain a perfect-match or mismatch nucleotide at the 
ligation site. All ligation oligonucleotides had identical tails for 
later amplification of all recognized hotspots with a single 
primer pair (universal amplification).  
The assays performed under different experimental conditions 
(e.g. buffer composition, enzyme concentration, ligation cycles, 
incubation times, temperature) allowed us to identify the 
annealing time to be a key variable (Supplementary Material, 
Fig. SI.2). In conventional MLPA approaches, the time required 
before starting ligation is about 16 h. However, our study 
showed that this step can be drastically reduced by about 120-
fold because comparable responses were obtained for a 7.5-
minute annealing time (Fig. 2A). These results were interpreted 
after considering the kinetic profile for the homogenous 
hybridization of short probes. In the liquid phase, the perfect-
match duplex formation quickly achieved maximum 
efficiency.25 Conventional MLPA requires long reaction times to 
ensure that annealing processes are completed, and considers 
not only a wide range of hybrid sizes (e.g. copy number 
Fig. 1 Scheme of the SNP discrimination principle. (A) Conventional MLPA (B) Array-MLPA. DLP: discrimination ligation probe, CLP: 
common ligation probe, ZCP: barcode probes 
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determination), but also the presence of stable intramolecular 
secondary structures and partially hybridized species. However, 
using ligation probes with similar thermodynamic properties 
(i.e. absence of loops and similar melting temperatures) can 
accelerate the process. Furthermore, ligation errors can be 
minimized if the genotyping is based on the relative responses 
between wild-type and mutant alleles.  
The next experiments focused on evaluating assay selectivity 
using the DNA templates from different human genome regions 
(Supplementary Material, Table SI.2).  
Ligation occurred selectively because no signal was recorded for 
the unmatched templates (t-test, p<0.05), while amplification 
took place for the expected complementary sequences. The 
results also confirmed that a mismatch at the 3’-end of the 
ligation probe completely prevented a non specific product 
from appearing (Fig. 2B). Therefore, the allelic variant 
discrimination for a specific polymorphism was possible 
because the generated signals of the perfect-match products 
were easy to distinguish from the background.  
 
2. Array detection 
The first modification for enabling the detection of ligation 
products was the structure of ligation oligonucleotides. In 
conventional MLPA, those contain a stuffer sequence to achieve 
the electrophoretic separation based on ligation product 
length. In array-MLPA, the discrimination ligation probe only 
contained a central region (hybridization barcode) between the 
amplification tail (5’-end) and the specific sequence (3’-end). 
Hence the sequences of these regions differed for each ligation 
probe, but length was the same. A second modification was 
related to detection through non coding barcodes. Estimated 
selectivity improved because their sequences had no homology 
to any human genome region. Thus each allele-specific product 
should hybridize to the specific barcode attached to the DVD 
surface. 
Solid-phase hybridization in the barcode format was done to 
simultaneously detect each product yielded from the previous 
discrimination process. The challenge consists in a proper 
oligonucleotide design by minimizing the cross annealing 
between oligonucleotides and the formation of secondary 
structures (i.e. self-annealing).  
A specific algorithm based on thermodynamic properties was 
used to choose the candidate sequences.26 Outputs were 
sequences that showed similar annealing to the template 
hotspot (∆G° = -28.1 ± 2.6 kcal mol-1) and the absence of 
significant hybridization to erroneous regions (∆G° < -8.8 kcal 
mol-1). Regarding SNP discrimination, the alteration expected 
due to the presence of a mismatch was comparable for all cases. 
In fact the estimated variation in standard free energies, 
expressed as the difference between the single-base mismatch 
(∆G°mm) and the perfect match (∆G°pm), ranged between 3.2 
and 4.6 kcal mol-1. 
For the immobilization of the barcode probes on the top DVD 
layer, indirect passive attaching (streptavidin-biotin interaction) 
was chosen. This option was versatile and provided an adequate 
immobilization yield (surface density of about 0.5 pmol/cm2). 
The hydrophobic nature of the polycarbonate surface (contact 
angle 90º) rendered a blocking stage unnecessary (e.g. low 
background signal) and simplified the washing protocols 
compared to other solutions. The barcode array involved 
shorter incubations and less restrictive conditions 
(hybridization and washing) than the conventional formats of 
DNA microarrays.27,28 After colorimetric staining, the 
hybridization assay between the probes and the ligation-
amplification products yielded blue spots with a diameter of 
500 ± 20 µm. These features enabled optical detection based on 
a DVD player/recorder (laser diode emission at 650 nm, 
numerical aperture 0.6) because its optical resolution was 
about 8.2 µm/pixel. In the absence of a solid deposit (reaction 
product), the reflection properties of the disc surface remained 
unchanged and the maximum intensity of the reflected beam 
was collected by the DVD drive (the background signal).  
Fig. 2 Fluorescence measurements after ligation-universal PCR (A) Effect of annealing time on assay response. Green circles: DNA 
templates (1000 copies). Red square: blank solutions. Dashed lines: error range. (B) Ligation selectivity depending on the ligation 
probe sequence: wild-type (WT-probe) and mutant (M-probe). ∗∗∗: test t, p-value<0.001; ∗∗: test t, p-value<0.01. Target SNP: 
rs4680 located in the COMT gene. 
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Fig. 3 (A) Effect of format multiplicity on discrimination capabilities for a specific SNP (rs2319398 located in the GSK3B gene). Green 
circles: signal of the wild-type mixture; red triangles: signal of the mutant mixture; blue squares: the discrimination factor. (B) 
Microarray spot intensities for different ligation reactions in the 10-plex format. T: Probes of the target SNP (rs2319398). A: 
Probes for Mix 1 (1-9 SNPs); B: Probes for Mix 2 (1, 10-18 SNPs); C: Probes for Mix 3 (1, 19-27 SNPs). ∗∗∗: test t, p-value<0.001 
 
However when the laser hit a microarray spot, the reflected 
laser beam attenuated. Consequently, the laser beam intensity 
that reached the photodiode of the DVD pickup diminished. 
A set of experiments was performed to check the designed 
oligonucleotides in hybridization efficiency terms in a single 
format, as described in the Supplementary Material (Fig. SI.3). 
The method output was an individual hybridization image, and 
the signal of each spot correlated with the recognition process 
(probe-allele-specific product). The signal-to-noise ratios, 
calculated from the mean spot signal and chip background, 
went up to 50. Unlike conventional MLPA, the detected signals 
did not change between products because the global number of 
nucleotides added per time unit during amplification 
(polymerase processability) was similar (test t, p<0.05). 
Therefore, the results demonstrated the capabilities for reliable 
detection in a DVD microarray format of MLPA products. 
 
3. Multiplexing capability 
In the DVD-array-MLPA method, the analytical performances 
associated with a particular variant could depend on the nature 
and number of hotspots that had been simultaneously assayed. 
As the studied technique exploited the high-throughput 
capabilities of the universal PCR and the barcode array, a set of 
experiments was run to evaluate the effect of multiplexing on 
genotyping a target SNP. The tested assay formats went from 
the single option (1-plex) to an approach for 28 polymorphisms 
(28-plex), as described in the Supplementary Material (Fig. SI.4 
and Fig. SI.5). 
The experiments indicated that a higher multiplexing capability 
was limited mainly for ligation yield, which agrees with previous 
studies.15,29 
Specific responses were observed in all the integrated formats 
(Fig. 3A). Thus ligation, universal PCR amplification and chip 
hybridization were achieved regardless of the number of 
products present in the reaction solutions. However, when 
assay complexity increased, the mismatch responses rose (up to 
8-fold) and the perfect-match responses and discrimination 
factor decreased by up to 25 % and 15 %, respectively. In order 
to understand these variations, alternative ligation reactions 
run in a 10-plex format were studied by changing nine targeted 
SNPs and keeping one constant (Fig. 3B). The results showed 
that the signal recorded for the specific SNP was the same, 
independently of mixture composition (ANOVA test, p-value 
0.3-0.7). These experiments demonstrated that the yield 
reduction was associated with weak cross-reactivity due to 
inherent enzymatic activities rather than to oligonucleotide 
incompatibilities. The ANOVA test showed that the spot 
intensities for all the polymorphisms were similar, irrespectively 
of assay format (mismatch complexes: p-value = 0.44 and 
perfect-match complexes: p-value = 0.86). All the genotypes 
were also correctly assigned, which indicates the success of the 
simultaneous allele-specific assays. In conclusion, the results 
demonstrated that the developed method was a useful 
medium-scale genotyping tool. 
 
4. Sample analysis 
The DVD-array-MLPA method performances were evaluated by 
genotyping clinically relevant SNPs from human samples (buccal 
swap and blood). Fig. 4 illustrates an example of the microarray 
images generated from the DVD detector outputs (assay for 28 
SNPs).  
The discrimination capability between the patient populations 
was studied from the training set samples. First, a scatterplot 
per studied SNP was created from the signal-to-noise responses 
of the wild-type probe against those of a mutant probe (Fig. 5A). 
Although different patients scored distinct optical intensities, 
probably caused by differences in process yields, data clouds 
were observed depending on the SNP population. Discriminant 
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functions were constructed as linear combinations of probe 
intensities. Here the objective was to automatically classify new 
observations as belonging to one population group or another. 
The discriminating functions obtained by the multiple 
regression model were statistically significant at the 95 % 
confidence level (p-value < 0.05).  
  
 
Fig. 4 Patient analysis. (A) Microarray layout indicating the printed probes. (B) Images obtained from a blood sample. Patient 
genotype: rs2235048 AA, rs762551 CC, rs2345039 AA, rs12248560 CT, rs6551665 AA, rs4680 AG, rs963468 GG, rs6313 AG, 
rs1799853 GG, rs4986893 GG, rs2284017 CC, rs4825476 GG, rs1800497 CC, rs16947 GG, rs1057910 AA, rs28371725 CC, rs1135840 
GG, rs2661319 GG, rs6277 AA, rs5443 CT, rs11246226 TT, rs13321783 CT, rs2518224 AA, rs4675690 CC, rs10042486 CC, rs852977 
CT, rs2345039 CG, and rs10482633 GT. 
 
Although slight variations were observed, the mean coefficients 
of the discriminant functions were 0.10±0.03 (function 1) and 
0.05±0.02 (function 2). These results confirmed that the 
method yielded similar responses for both alleles. The model’s 
goodness was confirmed because the percentage of correctly 
classified cases was higher than 98%, except for rs4680 and 
rs2319398, with 91 %. Fig. 5B shows that the differences among 
the three clusters gave us an unequivocal genotype 
classification.  
In a blind study, these discriminant functions, calculated from 
the training set, were used to classify patients’ answers from 
the validation set. The corresponding discriminant scores were 
calculated for each possible group (wild-type homozygote, 
mutant homozygote and heterozygote) and the genotype for 
each studied polymorphism was assigned (Supplementary 
Material, Table SI.6). The accuracy of the genotype calls by the 
microarray-based method was verified by analyzing the same 
genomic DNA extracts using the Illumina Goldengate platform. 
This high-throughput platform combines primer extension and 
ligation to generate allele-specific products, followed by a PCR 
for the amplification and hybridization to the codified beads for 
individual readout. The mean coincidence percentage was 96±4 
% (28 SNPs), with comparable values to other low-throughput 
simple methods.13,25,29-31 
The other analytical performances of the DVD-array MLPA 
method were also estimated for point-of-care applications.3 
Assay reproducibility was expressed as the relative standard 
deviation of the spot intensities for triplicate assays, and was 
lower than 15 %. The multiplexing results confirmed the 
method capability for the simultaneous genotyping of up to 28 
SNPs in a single DVD (8 samples per disc). In the developed 
method, both enzymatic steps and array-based detection lasted 
less than 2 h and 1.5 h, respectively, but was “hands off” for 
most of the time (2.6 h). Thus the estimated analysis time was 
under 5 h, which contrasts with the 2 days spent in conventional 
MLPA. As a smart sensing detector was used for DVD 
technology, the method is also portable, low-cost and requires 
very little specialized laboratory equipment. For instance, the 




Volunteers, and the patients diagnosed by specialist 
psychiatrists, were recruited for the present study according to 
ethics after giving informed consent. Subjects were divided for 
method optimization (n=15) and validation (n=35). Buccal 
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Fig 5. (A) The XY scatter plots created from the spot intensities of the wild-type probe and mutant probes: rs2345039 (top) and 
rs2661319 (bottom). (B) Plots of discrimination function: rs2345039 (top) and rs2661319 (bottom). Cross symbols indicate the 
group centroids. Data: 15 human samples of the training set (3 replicates). 
 
Ligation-based discrimination reaction 
Two probe mixtures (alleles A and B) were prepared, and 
comprised 28 oligonucleotide sets (Supplementary Material). 
Each set consisted of two oligonucleotides: the left probe 
oligonucleotide (LPO) and the right probe oligonucleotide 
(RPO). LPO is allele-specific at the 3’-end and has a 5’-tail for 
amplification. RPO is a 5′-phosphorylated oligonucleotide that 
hybridizes to the directly adjacent target sequences. 
RPO also contains a 3’-tail with a specific barcode for each 
targeted polymorphism and a common sequence for 
amplification. The concentration of each LPO and RPO was 1.3 
nM in Tris-EDTA buffer (TEB: Tris-HCl 10 mM pH 8, EDTA 0.1 
mM). Two reaction solutions (4 µL) were prepared. They 
contained genomic DNA from the patients’ sample (30 ng) and 
an aliquot of each probe mixture (0.75 µL). After DNA 
denaturation (98°C, 5 min) and probe annealing (60ºC, 7.5 min), 
the ligation mixture was added, which contained 0.5 µL of Salsa 
Ligase-65 (MRC-Holland) in a final 20-µL volume. Then ligation 
was performed (60 °C, 7.5 min), followed by enzyme 
deactivation (98 °C, 5 min). 
 
Universal amplification 
Two PCR reaction mixtures were prepared. They contained Tris-
HCl at 75 mM pH 9.0, KCl at 50 M, (NH4)2SO4 at 20 mM, MgCl2 
at 3 mM and dNTPs at 100 µM. The first mixture contained a 
type-A forward primer (digoxigenin-ACTTCGTCAGTAACGGAC) 
and a reverse primer (GTCTGCCTATAGTGAGTC) at 300 nM. The 
second mixture contained a type-B forward primer 
(digoxigenin-GAGTCGAGGTCATATCGT) and the same reverse 
primer. To each mixture (10 µL), the ligation product solution 
was added. The cycling conditions were 35 denaturation cycles 
(95 °C, 30 s), primer annealing (64 °C, 30 s), elongation (72 °C, 
30 s), and a final elongation (72 °C, 10 min). For optimization, 
process efficiency was monitored by a fluorescence plate reader 
(EX485 and EM535 nm, Victor 3TM V1420, Perking Elmer) after 
SYBR Safe-staining in a 96-well black polystyrene plate. 
 
Universal hybridization 
For probe immobilization, each biotinylated probe (50 nM) in 
printing buffer (50 mM carbonate buffer, 1% glycerol (v/v) and 
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streptavidin (10 mg/L) at pH 9.6) was transferred to the DVD 
disc surface (50 nL) with a non contact printer (relative humidity 
90%, AD 1500 BioDot Inc.). The microarray layout consisted of 
eight arrays of 17×6 dots each, with a 1-mm track pitch 
corresponding to the targeted genes, positive controls and 
negative controls (immobilization and hybridization). For 
hybridization, 2 µL of purified PCR product were mixed with 38 
µL of the hybridization solution composed of SSC buffer 1× 
(sodium citrate 15 mM, NaCl 150 mM, pH 7), 35% formamide, 
and 1.5× Denhardt’s reagent. The solution was denatured by 
heating (95 °C, 5 min), transferred to the slide surface and 
incubated (37 °C, 1 h). Discs were gently washed for 1 min with 
diminishing dilutions of SSC (SSC 1×, SSC 0.5×, SSC 0.05×).  
Colorimetric staining consisted in an immunoreaction. 
Subsequently, the 1-mL mix of 1:2500 sheep antidigoxigenin-
antibody (Abcam) and 1:300 antisheep-antibody labelled with 
horse radish peroxidase (Abcam) in phosphate-buffered saline 
solution containing 0.05 % detergent Tween-20 (PBST) was 
dispensed to the DVD and was incubated (room temperature, 
30 min). After washing with PBST and water, 1 ml of TMB 
(3,3′,5,5′-tetramethylbenzidine) was spread on the slide 
surface, incubated (room temperature for 8 min) and washed 
with water. The disc was placed in the DVD-drive and was 
scanned by a 650 nm-laser. The signals from the detection areas 
were processed for digitization and deconvoluted into a gray-
scale image (Tagged Image File Format, colour depth 16 bit, 
scale 0-65535). The optical intensity signals of each spot were 
quantified by in-home software.  
 
Discrimination criteria 
The Statgraphics Centurion statistical package for Windows v.16 
was used for the data analysis. A genotype decision rule was 
constructed based on the discriminant functions calculated 
from the spot intensities of the wild-type and mutant probes 
(multiple regression). The functions for polymorphism i were: Di 
= ci0 + ciA XiA + ciB XiB, where ci are the regression coefficients and 
Xi are the spot intensities for each allele. By substituting the 
data for a new sample (XiA and XiB), a score can be calculated 
and a patient can be classified and placed in a population group. 
The squared Mahalanobis distances from the group centroids 
were calculated in the space of the discriminant functions for 
each observation. 
Conclusions 
Quantitative PCR, used as a genotyping technique, is limited by 
its low-multiplexing capabilities, while sequencing techniques 
pose major technological barriers for a wide range of clinical 
scenarios. Our study developed a DVD-array-MLPA approach 
that overcomes some of these restrictions. This technique is 
able to perform the simultaneous detection of several nucleic 
acid sequences (low-middle scale). Key elements are based on 
ligation-mediated discrimination, amplification employs 
universal primers and the latter hybridization uses barcode 
probes. Furthermore, the integration with consumer electronic 
technology, such as a compact disc, provides additional 
advantages that derive from their low-cost materials and user-
friendly optical read-outs. The result is a cheap, versatile, fast, 
portable and parallel format that provides a commercially 
affordable analytical system. Nevertheless, more efforts are 
required towards an automated assay (i.e. microfluidic DVD-
based disc). Since the genotyping method includes PCR for 
universal amplification, the next step could be directed to 
isothermal techniques in order to simplify the required auxiliary 
equipment.  
Regarding clinical applications, the discrimination of DNA 
variants (polymorphisms or point-mutations) is basic to 
advance in pharmacogenomics and genetic diagnoses. The 
reported results demonstrate that this biosensing methodology 
is extremely powerful for analysing high-identity sequences, as 
required in personalized medicine. In short, this research 
contributes to the important scientific challenge of developing 
affordable analytical tools for mass access to specific genetic 
information. 
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